CeriBell, Inc.CBLL

$18.03+0.75 (+4.34%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$679M
Small-cap
-22%
2024 — today
10-Year Price
-30%
2024 — today
52-Week Range
$10.92$23.43
Current $18.03· 57%

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

Valuation in context

P/E ratio
-11.1
N/A
Not meaningful — company is unprofitable
P/B ratio
4.8
Historically pricey
Historically pricey — last 10 years
FCF Yield
-7.3%
Historically low
Historically low relative to the last 10 years
Free · No credit card needed

Get alerted when CBLL is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.